Purac to build new plant for biomedical resorbable polymers in the USA
Purac announces the investment in a new manufacturing facility for its biomedical polymers. The plant is meant to support the growing resorbable polymers business of Purac Biomaterials. Purac currently operates a plant for biomedical polymers in The Netherlands. This second facility will be built in the USA. The investment for this new plant will be EUR 15 million. The construction of the facility will start in 2011 and is expected to be completed before the end of the year.
Arno van de Ven, Purac Vice President Chemicals & Pharma comments: “This represents an important step in the biomedical polymer business and shows Purac’s continued commitment to this market. It provides us with the capability to support the growth of our existing and new business partners.”
Besides an increase in the production capacity, the new facility will bring Purac Biomaterials more flexibility and a more balanced presence in its global markets.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Vetter Starts Operations in Its Center for Visual Inspection and Logistics - Site enlargement enables increased capacity for state-of-the-art quality control and storage
Entrainment_(Biomusicology)
Caprotec bioanalytics appoints Prof. Dr. Metternich as Managing Director, Chief Business Officer and Chief Operating Officer
Laryngeal_mask_airway

Happy hour for time-resolved crystallography - Researchers simplify time-resolved X-ray crystallography
Testing the Efficacy of New Gene Therapies More Efficiently

Scorpion venom to shuttle drugs into the brain - Chlorotoxin, a small protein with blood-brain barrier permeability modified to drug the brain

New approach explains how protein complexes regulate cancer genes - New starting point for improved cancer therapies
Category:Pharmaceutical_microbiology
Cipher receives Patent Notice of Allowance for CIP-ISOTRETINOIN

More efficient biosolar cells modelled on nature - By combining light-collecting and photosynthesis proteins of different types, more energy can be produced
